Skip to content
Disclosery

EXANE DERIVATIVES: BBIO position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on BBIO, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 0 BBIO shares at 2022-03-31 per its 13F-HR filed 2022-04-22.

the latest 13F is the newest step

  1. period ended2022-03-31
    13F 0 shares
    Change vs previous 13F -3,246 shares

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2021-12-31
    13F 3,246 shares
    Change vs previous 13F +999 shares

    0.01% of the 13F portfolio, value $54,141.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-09-30
    13F 2,247 shares
    Change vs previous 13F -321 shares

    0.03% of the 13F portfolio, value $105,313.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-06-30
    13F 2,568 shares
    Change vs previous 13F +930 shares

    0.04% of the 13F portfolio, value $161,087.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-03-31
    13F 1,638 shares
    Change vs previous 13F +1,143 shares

    0.03% of the 13F portfolio, value $100,896.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2020-12-31
    13F 495 shares
    Change vs previous 13F not available

    0.01% of the 13F portfolio, value $35,198.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).